1O8

(2E,4E,6Z,8E)-8-(3,4-dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid

Created:	2013-04-19
Last modified:	2013-11-13

Find Related PDB Entry
1 entries where 1O8 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	44
Chiral Atom Count	0
Bond Count	45
Aromatic Bond Count	6

2D diagram of 1O8

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2E,4E,6Z,8E)-8-(3,4-dihydronaphthalen-1(2H)-ylidene)-3,7-dimethylocta-2,4,6-trienoic acid
Systematic Name (OpenEye OEToolkits)	(2E,4E,6Z,8E)-8-(3,4-dihydro-2H-naphthalen-1-ylidene)-3,7-dimethyl-octa-2,4,6-trienoic acid
Formula	C₂₀ H₂₂ O₂
Molecular Weight	294.387
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)\C=C(\C=C\C=C(/C=C2/c1ccccc1CCC2)C)C
SMILES	CACTVS	3.370	CC(C=CC=C(C)C=C1CCCc2ccccc12)=CC(O)=O
SMILES	OpenEye OEToolkits	1.7.6	CC(=CC(=O)O)C=CC=C(C)C=C1CCCc2c1cccc2
Canonical SMILES	CACTVS	3.370	CC(/C=C/C=C(C)\C=C1/CCCc2ccccc12)=C\C(O)=O
Canonical SMILES	OpenEye OEToolkits	1.7.6	C/C(=C\C(=O)O)/C=C/C=C(/C)\C=C\1/CCCc2c1cccc2
InChI	InChI	1.03	InChI=1S/C20H22O2/c1-15(7-5-8-16(2)14-20(21)22)13-18-11-6-10-17-9-3-4-12-19(17)18/h3-5,7-9,12-14H,6,10-11H2,1-2H3,(H,21,22)/b8-5+,15-7-,16-14+,18-13+
InChIKey	InChI	1.03	PPGNMFUMZSAZCW-VOYUZAMQSA-N

Drug Info: DrugBank

DrugBank ID	DB12316
Name	9CUAB30
Groups	investigational
Description	9 Cuab30 has been used in trials studying the treatment and prevention of HER2/Neu Positive, HER2/Neu Negative, No Evidence of Disease, Estrogen Receptor Negative, and estrogen receptor positive, among others.
Synonyms	9CUAB30 RETINOID 9CUAB30
Categories	Fatty Acids Lipids
CAS number	205252-57-9

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3098771
PubChem	9904203
ChEMBL	CHEMBL3098771

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.